Azithromycin vs doxycycline in the treatment of inclusion conjunctivitis

American Journal of Ophthalmology

Volumn 135, Issue 4, 2003, Pages 447-451

  Katusic, Damir ^a   Petricek, Igor ^a,c,g   Mandic, Zdravko ^c   Petric, Ivanka ^a,c   Salopek Rabatic, Jasminka ^d   Kruzic, Vladimira ^e   Oreskovic, Katarina ^f   Sikic, Jakov ^a   Petricek, Goranka ^b  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d University of Zagreb School of Medicine   (Croatia)

^e Zagreb Institute of Public Health   (Croatia)

^f PLIVA CROATIA LTD   (Croatia)

^g NONE   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FLUORESCENT ANTIBODY TECHNIQUE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0037376401     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)02094-9     Document Type: Article

References (23)

1. Morrow G.L., Abbott R.L. Conjunctivitis. Am Fam Physician. 57:1998;735-746.
2. Garland S.M., Malatt A., Tabrizi S., et al. Chlamydia trachomatis conjunctivitis prevalence and association with genital tract infection . Med J Aust. 162:1995;363-366.
3. Rao S.K., Madhavan H.N., Padmanabhan P., et al. Ocular chlamydial infections clinicomicrobiological correlation . Cornea. 15:1996;62-65.
4. Nakagawa H. Treatment of chlamydial conjunctivitis. Ophthalmologica. 211:(Suppl 1):1997;25-28.
5. Peters D.H., Heather A.F., McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs. 44:1992;750-799.
6. Guidelines for the treatment of sexually transmitted diseases. Morb Mortal Wkly Rep. 47:(RR-1):1998;1-111.
7. Bailey R.L., Arrulrndan P., Whittle H.C., Mabey D.C. Randomized controlled trial of single-dose azithromycin in the treatment of trachoma. Lancet. 342:1993;453-456.
8. Tabbara K.F., Abu el-Asrar A.M., al-Omar O., Choudhury A.H., al-Faisal Z. Single-dose azithromycin in the treatment of trachoma. A randomized controlled study. Ophthalmology. 103:1996;842-846.
9. Dawson C.R., Schachter J., Sallam S., Sheta A., Rubinstein R.A., Washton H. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis. 24:1997;363-368.
10. Schachter J., West S.K., Mabey D., Dawson C.R., Bobo L., Bailey R., Vitale S., Quinn T.C., Sheta A., Sallam S., Mkocha H., Mabey D., Faal H. Azithromycin in control of trachoma. Lancet. 354:1999;630-635.
11. Salopek J., Strugar J. Azithromycin in the treatment of chlamydial conjunctivitis. 4th International Conference on Macrolides, Azalides, Streptogramins, and Ketolides, Barcelona, Spain, Jan:1998;21-23.
12. Salopek-Rabatic J. Chlamydial conjunctivitis in contact lens wearers Successful treatment with single dose azithromycin . CLAO J. 27:2001;209-211.
13. Ronnerstam R., Persson K., Hansson H., Renmarker K. Prevalence of chlamydial eye infection in patients attending an eye clinic, a VD clinic, and in healthy persons. Br J Ophthalmol. 69:1985;385-388.
14. Viswalingam N.D., Darougar S., Yearsley P. Oral doxycycline in the treatment of adult chlamydial ophthalmia. Br J Ophthalmol. 70:1986;301-304.
15. Hammershlag M.R., Gelling M., Roblin P.M., Kutlin A., Jule J.E. Treatment of neonatal chlamydial conjunctivitis with azithromycin. Pediatr Infect Dis J. 17:1998;1049-1050.
16. Steingrimsson O., Olafsson J.H., Thorarinsson H., Ryan R.W., Johnson R.B., Tilton R.C. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis. 21:1994;43-46.
17. Stamm W.E., Hicks C.B., Martin D.H. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double blind study. JAMA. 274:1995;545-549.
18. Thorpe E.M., Stamm W.E., Hook E.W. III. Chlamydial cervicitis and urethritis single dose treatment compared with doxycycline for seven days in community based practices . Geniturin Med. 72:1996;93-97.
19. Hillis S.D., Coles F.B., Litchfield B. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use effectiveness study in public health settings. Sex Transm Dis. 25:1998;5-11.
20. Carlin E.M., Barton S.E. Azithromycin as the first-line treatment of non-gonoccocal urethritis (NGU) a study of follow up rates, contact attendance, and patients' treatment preference . Int J STD AIDS. 7:1996;185-189.
21. Haddix A.C., Hillis S.D., Kassler W.J. The cost effectiveness of azithromycin for chlamydia trachomati infections in women. Sex Transm Dis. 22:1995;274-280.
22. Magid D., Douglas J.M., Schwartz J.S. Doxycycline compared with azithromycin for treating women with genital chlamydia trachomatis infections an incremental cost-effectiveness analysis . Ann Intern Med. 124:1996;389-399.
23. Petitta A., Hart S.M., Bailey E.M. Economic evaluation of three methods of treating urogenital infections in the emergency department. Pharmacotherapy. 19:1999;648-654.